Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-04 4:05 pm Sale | 2024-12-02 | 13D | BeiGene, Ltd. BGNE | HHLR ADVISORS LTD. | 125,045,741 9.000% | -21,997,317 (-14.96%) | Filing History |
| 2024-11-14 4:34 pm Purchase | 2024-09-30 | 13G | Aligos Therapeutics, Inc. ALGS | HHLR ADVISORS LTD. | 125,069 4.000% | 125,069 (New Position) | Filing History |
| 2024-11-14 4:33 pm Purchase | 2024-09-30 | 13G | ArriVent BioPharma, Inc. Common Stock AVBP | HHLR ADVISORS LTD. | 4,484,672 13.400% | 4,484,672 (New Position) | Filing History |
| 2024-11-14 4:32 pm Purchase | 2024-09-30 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | HHLR ADVISORS LTD. | 1,582,635 3.900% | 1,582,635 (New Position) | Filing History |
| 2024-02-14 4:41 pm Sale | 2023-12-31 | 13G | Smart Share Global Limited EM | HHLR ADVISORS LTD. | 62,367,293 14.000% | -260,600 (-0.42%) | Filing History |
| 2024-02-14 4:39 pm Purchase | 2023-12-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | HHLR ADVISORS LTD. | 3,879,426 9.900% | 338,125 (+9.55%) | Filing History |
| 2024-02-14 4:39 pm Sale | 2023-12-31 | 13G | Cytek Biosciences, Inc. CTKB | HHLR ADVISORS LTD. | 6,657,030 4.900% | -2,027,500 (-23.35%) | Filing History |
| 2024-02-14 4:37 pm Purchase | 2023-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | HHLR ADVISORS LTD. | 238,857 8.200% | 146,466 (+158.53%) | Filing History |
| 2024-02-14 4:36 pm Sale | 2023-12-31 | 13G | MOGU Inc. MOGU | HHLR ADVISORS LTD. | 254,253,005 11.800% | -6,921,000 (-2.65%) | Filing History |
| 2024-02-14 4:35 pm Sale | 2023-12-31 | 13G | Bright Scholar Education Holdings Limited BEDU | HHLR ADVISORS LTD. | 3,952,572 12.600% | -33,224 (-0.83%) | Filing History |
| 2024-02-14 4:35 pm Sale | 2023-12-31 | 13G | Agora, Inc. API | HHLR ADVISORS LTD. | 19,287,300 5.100% | -712,700 (-3.56%) | Filing History |
| 2023-08-18 4:32 pm Purchase | 2022-12-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | HHLR ADVISORS LTD. | 3,541,301 9.900% | 917,377 (+34.96%) | Filing History |
| 2023-06-30 4:05 pm Sale | 2023-06-28 | 13D | I-Mab IMAB | HHLR ADVISORS LTD. | 15,891,211 8.300% | -629,349 (-3.81%) | Filing History |
| 2023-02-14 4:14 pm Purchase | 2023-02-14 | 13D | BeiGene, Ltd. BGNE | HHLR ADVISORS LTD. | 147,043,058 10.900% | 7,800 (+0.01%) | Filing History |
| 2023-02-14 4:13 pm Sale | 2022-12-31 | 13G | On Holding AG ONON | HHLR ADVISORS LTD. | 5,468,504 1.900% | -10,505,246 (-65.77%) | Filing History |
| 2023-02-14 4:13 pm Sale | 2022-12-31 | 13G | Root, Inc. ROOT | HHLR ADVISORS LTD. | 138,977 1.500% | -254,768 (-64.70%) | Filing History |
| 2023-02-14 4:10 pm Sale | 2022-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | HHLR ADVISORS LTD. | 92,391 5.800% | -2,212 (-2.34%) | Filing History |
| 2023-02-14 4:09 pm Sale | 2022-12-31 | 13G | Cytek Biosciences, Inc. CTKB | HHLR ADVISORS LTD. | 8,684,530 6.400% | -72,500 (-0.83%) | Filing History |
| 2023-02-14 4:08 pm Sale | 2022-12-31 | 13G | Gossamer Bio, Inc. GOSS | HHLR ADVISORS LTD. | 4,974,041 5.300% | -2,446,933 (-32.97%) | Filing History |
| 2023-02-14 4:08 pm Sale | 2022-12-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | HHLR ADVISORS LTD. | 2,623,924 7.600% | -296,099 (-10.14%) | Filing History |